1. Home
  2. SANA vs VINP Comparison

SANA vs VINP Comparison

Compare SANA & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANA
  • VINP
  • Stock Information
  • Founded
  • SANA 2018
  • VINP 2009
  • Country
  • SANA United States
  • VINP Brazil
  • Employees
  • SANA N/A
  • VINP N/A
  • Industry
  • SANA Medicinal Chemicals and Botanical Products
  • VINP Investment Managers
  • Sector
  • SANA Health Care
  • VINP Finance
  • Exchange
  • SANA Nasdaq
  • VINP Nasdaq
  • Market Cap
  • SANA 519.8M
  • VINP 616.8M
  • IPO Year
  • SANA 2021
  • VINP 2021
  • Fundamental
  • Price
  • SANA $1.63
  • VINP $10.22
  • Analyst Decision
  • SANA Strong Buy
  • VINP Strong Buy
  • Analyst Count
  • SANA 5
  • VINP 2
  • Target Price
  • SANA $9.50
  • VINP $13.50
  • AVG Volume (30 Days)
  • SANA 3.8M
  • VINP 100.4K
  • Earning Date
  • SANA 05-07-2025
  • VINP 05-08-2025
  • Dividend Yield
  • SANA N/A
  • VINP 6.31%
  • EPS Growth
  • SANA N/A
  • VINP N/A
  • EPS
  • SANA N/A
  • VINP 0.34
  • Revenue
  • SANA N/A
  • VINP $97,136,413.00
  • Revenue This Year
  • SANA N/A
  • VINP $29.71
  • Revenue Next Year
  • SANA N/A
  • VINP $15.39
  • P/E Ratio
  • SANA N/A
  • VINP $30.30
  • Revenue Growth
  • SANA N/A
  • VINP 32.21
  • 52 Week Low
  • SANA $1.48
  • VINP $9.01
  • 52 Week High
  • SANA $10.50
  • VINP $11.62
  • Technical
  • Relative Strength Index (RSI)
  • SANA 33.34
  • VINP 52.86
  • Support Level
  • SANA $2.18
  • VINP $10.02
  • Resistance Level
  • SANA $2.43
  • VINP $10.37
  • Average True Range (ATR)
  • SANA 0.26
  • VINP 0.38
  • MACD
  • SANA -0.08
  • VINP 0.02
  • Stochastic Oscillator
  • SANA 9.84
  • VINP 56.94

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

About VINP Vinci Partners Investments Ltd.

Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.

Share on Social Networks: